Listen "The Silent Killer: Who has the killer apps? With Dimerix and PYC Therapeutics"
Episode Synopsis
We speak to Dimerix CEO Dr Nina Webster about why investors are thrilled with her company, as it nears the midway point for its Phase III clinical trial for the rare disease focal segmental glomerulosclerosis (FSGS).And we talk to PYC Therapeutics CEO Dr Rohan Hockings about how his company's tech actually works to treat polycystic kidney disease. Support the showProduced by Rachel Williamson and Charis Palmer. Music and effect credits to Ziso, Inspector J, Seth Parson and Boom Library.
More episodes of the podcast PHASE3
VAXXED: Game on, with BASE and WEHI
19/11/2024
NUKED: Patent puzzles, with FB Rice
01/10/2024
ZARZA We are Zarza, the prestigious firm behind major projects in information technology.